Position in IBRX
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$123,673
+$15,327 QoQ
Shares Held
14,126
0.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#268
of 401 holders
Holding Since
Mar 2023
14 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in IBRX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Norris Financial Group, LLC holds $6,694,632 across 4 Biotechnology names. IBRX ranks #4 (1.8% of the industry book) .
All Filings in IBRX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $123,673 | 14,126 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $108,346 | 14,126 | Shares | Sole | 2026-05-20 | |
| 2025-12-31 | $27,969 | 14,126 | Shares | Sole | 2026-05-20 | |
| 2025-09-30 | $34,749 | 14,126 | Shares | Sole | 2026-05-20 | |
| 2025-06-30 | $37,292 | 14,126 | Shares | Sole | 2026-05-20 | |
| 2025-03-31 | $42,519 | 14,126 | Shares | Sole | 2026-05-20 | |
| 2024-12-31 | $36,162 | 14,126 | Shares | Sole | 2026-05-20 | |
| 2024-09-30 | $52,548 | 14,126 | Shares | Sole | 2026-05-20 | |
| 2024-06-30 | $86,900 | 13,750 | Shares | Sole | 2026-05-20 | |
| 2024-03-31 | $59,070 | 11,000 | Shares | Sole | 2026-05-20 | |
| 2023-12-31 | $55,220 | 11,000 | Shares | Sole | 2026-05-20 | |
| 2023-09-30 | $18,590 | 11,000 | Shares | Sole | 2026-05-20 | |
| 2023-06-30 | $30,580 | 11,000 | Shares | Sole | 2026-05-20 | |
| 2023-03-31 | $21,840 | 12,000 | Shares | Sole | 2026-05-20 | |
| No filing history on record for this holder in this stock. | ||||||